| Kooperationen:
Die schlimmsten Fehler bei der Gründung und Führung
Mediation im Medizinrecht
|
| Wiesbaden 17.12.2011 |
|
| 109. Fortbildungsseminar der Österreichischen Gesellschaft für Chirurgie (ÖGC) |
| Salzburg 16.12.2011 - 17.12.2011 |
| Leberchirurgie,
Stoma |
|
| Ausmessung von Aortenprothesen |
| Bad Nauheim 16.12.2011 |
|
| Seminareinladung 16. AMG-Novelle - Referentenentwurf im Überblick
|
| Bonn 15.12.2011 |
|
| EASL Special Conference “Liver Transplantation” |
| Lissabon 15.12.2011 - 17.12.2011 |
|
| Post San Antonio Breast Cancer Symposium
|
| Düsseldorf 14.12.2011 |
| Neo- / Adjuvante Therapie und deren Prädiktion;
Operative Therapie und Strahlentherapie;
Behandlung des fortgeschrittenen Mammakarzinoms – Bewährtes und neue Substanzen;
Spezielle Behandlungssituationen – der seltene Fall mit wenig Evidenz |
|
| BEGO Medical-Workshop
|
| Bremen 14.12.2011 |
|
| Current Concepts in Joint Replacement - Winter |
| Orlando 14.12.2011 - 17.12.2011 |
|
| CAPA is King Virtual Conference: Tools, Tips and Techniques for Assuring Compliance |
| online 13.12.2011 |
| Today, more than two-thirds of all FDA warning letters cite CAPA (Corrective & Preventative Action) deficiencies in how a firm
conducts related investigations.
To make matters even worse, the FDA doesn't just look for compliance, but also for risk. Inspectors want to see that companies
are proactively identifying and fixing risks as well. Also, agency investigators now scrutinize CAPAs to uncover the dotted lines
that connect drug and device sponsors to problems beyond CAPA.
Example: It's no longer enough for you to catch a problem and halt distribution. Now you've got to track down units that are already
in the field and manage them properly, too.
Developing a successful CAPA program has never been more important. Yet, history proves that drug and device firms have a
steep learning curve.
As bad as it seems, there is a silver lining. Drug- and device makers that demonstrate their CAPA programs are effective and
adequate, are in line for the FDA's blessing.
So suppose you could invite the top CAPA experts in the land into your conference room -- industry and legal pros with decades
of FDA experience under their belts, now working with regulated manufacturers like you -- and discover how to institute CAPA
practices that all but guarantee a close-out letter.
Suppose they spent a full day of give and take with you and your staff, briefing you on the latest FDA thinking, plus proven
techniques that have worked for companies like yours.
It's not fantasy, but reality. And it takes place only a few short weeks from now.
Clear your calendar for Tuesday, Dec. 13, and plan to spend the day near a computer screen. It's the CAPA event of the year,
a virtual regulatory conference sponsored by FDAnews where Washington comes to you.
|
|
| JuraHealth Congress 2011 |
| Dresden 13.12.2011 |
| Aufgabenübertragung, Akademisierung, Personalgewinnung |
|
